PTVE - Pactiv Evergreen: Attractive FCF Yield Profile Once Cost Savings Program Ends
2024-03-21 09:58:26 ET
Summary
- I upgrade my rating for Pactiv Evergreen stock from neutral to buy due to early signs of demand recovery and successful cost reduction efforts.
- PTVE's 4Q23 revenue fell, but EBITDA improved, indicating margin expansion. The stock price dropped due to a weak FY24 EBITDA guide.
- Risks include potential missteps in the restructuring program.